We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
ESTRO
Menu
  • Corporate Members
  • E-Library
  • Twitter
  • Linked In
  • Facebook
  • Instagram
  • Join
  • MyESTRO
Search Opener
  • About ESTRO
  • Membership
  • School
  • Workshops
  • Congresses
  • Science
  • Education
  • Advocacy
  • Corporate Members
  • E-Library
  1. Home
  2. About ESTRO
  3. Newsroom
  4. Newsletter
  5. Read it before your patients

Achieve recognition of all radiotherapy professions

Read it before your patients
  • 20/06/2022

    Patterns of relapse after adjuvant (chemo)radiation for cervical cancer in a phase III clinical trial (PARCER): an evaluation of updated NRG Oncology /RTOG target delineation guidelines - Read It

  • 13/06/2022

    Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond - Read It

  • 07/06/2022

    Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase III trials of the STAMPEDE platform protocol - Read It

  • 30/05/2022

    Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomised PREOPANC Trial - Read It

  • 23/05/2022

    Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase III Randomised Controlled Trial - Read It

  • 20/05/2022

    GEC-ESTRO ACROP Prostate Brachytherapy Guidelines - Read It

News Pages: 1 2 3 4 5 6 7 8 9 10
  • Newsletter 2019
  • Newsletter 2018
  • Newsletter 2017
  • 2019 Radiobiology Articles

Corner Editor: Philippe Lambin

Submit your article

Corner Editor: Evert van Limbergen

Submit your article
  • Contact
  • Privacy Statement
  • Sitemap
  • Careers
  • FAQ
  • Twitter
  • Linked In
  • Facebook
  • Instagram

© The European SocieTy for Radiotherapy and Oncology. All rights reserved. ESTRO Avenue Marnix 17, 1000 Brussels . +32 477 271 125.